← All indications
Deglutition Disorders
Difficulty in SWALLOWING which may result from neuromuscular disorder or mechanical obstruction. Dysphagia is classified into two distinct types: oropharyngeal dysphagia due to malfunction of the PHARYNX and UPPER ESOPHAGEAL SPHINCTER; and esophageal dysphagia due to malfunction of the ESOPHAGUS.
Subtype terms (1)
More specific conditions that are subtypes of Deglutition Disorders in the MeSH hierarchy.
- Esophageal Motility Disorders
9 drugs approved
Drugs by status
Phase 4 trials (3)
Phase 3 trials (9)
Phase 2 trials (18)
Phase 1 trials (14)
Organizations
Organization Involved with Phase 4 Indications (5)
Organization Involved with Phase 3 Indications (7)
Organization Involved with Phase 2 Indications (14)
- Swedish Orphan Biovitrum
- Amgen
- National Institutes of Health (NIH)
- National Cancer Institute (NCI)
- Hoosier Cancer Research Network
- Hospital de Mataró
- NRG Oncology
- Radiation Therapy Oncology Group
- University of South Florida
- Mayo Clinic
- University of Calgary
- Vanderbilt University
- Icahn School of Medicine at Mount Sinai
- University of Central Arkansas
Organization Involved with Phase 1 Indications (8)
Organization Involved with Other Experimental Indications (14)
- Banner Health
- Rockefeller University
- University of Arizona
- Baylor University
- Instituto do Cancer do Estado de São Paulo
- Justin Parker Neurological Institute
- Northwestern University
- University of Rochester
- Boulder Neurosurgical Associates
- University of Montreal
- Winthrop University
- More Foundation
- University of Burgundy
- Aymes